Here at SensorMed we have been working hard to bring our first device offering, the SensorMed Spinal Needle, to market by Q4 of 2010. This is a relatively short runway for commercialization. However, the road ahead contains some significant milestones for us. One of our primary objectives is to ensure that we complete the development of our prototype device as quickly as possible. Our timeline for prototype completion is set for October of this year, and our Chief Engineer William Milam is working diligently to ensure that we stay consistent with this projection. The mechanical engineering of the prototype, and ultimately the commercialized device, will be outsourced to ME Martin Bauer for completion.

In the meantime, we need to focus on preparing for the device's clinical trials that will take place once the prototype has been completed. These trials will be conducted under the supervision of an institutional review board, most likely at the Universtiy of Tennesse Medical Center. We have already reached out to medical researchers at UTMC in order to facilitate research collaboration between the Medical Center and SensorMed. The valuable feedback that we gain from these medical professionals during our various stages of development will allow us to develop the highest quality device possible with maximum benefits to both health care professionals and patients.